mail
versión imprimible
 
 

3rd RAS/MAPK Pathway Targeted Drug Discovery Summit

Evvnt Promotion / evvnt
-
22.02.2022 - 24.02.2022  Online, USA
Time: 9:00 AM - 3:30 PM
 
Temas de la conferencia
For decades, RAS proteins have been considered “undruggable.” This all changed following the recent approval of the first-ever targeted KRAS G12C therapy, marking a major landmark for this community. This breakthrough has certainly laid out a roadmap for future success, with more investment and innovation in the field than ever before, particularly within emerging discovery strategies being pursued by the biopharma industry.
Organizador profesional (PCO)
Hanson Wade
 

Información e inscripción:

https://go.evvnt.com/913421-2?pid=4832
Ms. Georgina FitzGerald
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 1899.00 - USD 3796.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnologie und MedizinCenter of ExcellenceÖsterreichische Akademie der ÄrzteEuropean Public Health Association (EUPHA)newTreeHelix - Forschung & Beratung Wien